You don't need to be signed in to listen to BMJ Group Podcasts, but you can register here to receive updates about other BMJ Group products and services via our Group site.

Hepatocellular carcinoma

21 Jun, 10 | by BMJ Group

In this podcast Professor Alexander Gerbes (Klinikum of the University of Munich, Germany, and an associate editor of Gut) talks to Professir Franco Trevisani(Università di Bologna, Italy) about the results of his research into treatment of elderly patients for hepatocellular carcinoma.

See also:
Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients

Hepatocellular carcinoma [13:16m]:

Bacterial composition in appendicitis

13 May, 10 | by BMJ Group

Dr Herbert Tilg (of Gut and the Medizinische Universität Innsbruck) talks to Dr Alexander Swidsinski (Charité - Universitätsmedizin Berlin) about his paper on bacterial composition in appendicitis.

Related Gut article: Acute appendicitis is characterized by local invasion with Fusobacterium  nucleatum/necrophorum.

Bacterial composition in appendicitis [26:12m]:

Dietary Folate, Alcohol, and B Vitamins in Relation to LINE-1 Hypomethylation in Colon Cancer

17 Feb, 10 | by BMJ Group

In this podcast, Dr William Grady (The Fred Hutchinson Cancer Centre, and an associate editor on Gut) talks to Eva Schernhammer (Harvard School of Public Health) and Shuji Ogino (Dana-Faber Cancer Centre) about their paper on B vitamins and hypomethylation in colon cancer.

For the related Gut article, please follow this link:  Dietary Folate, Alcohol, and B Vitamins in Relation to LINE-1 Hypomethylation in Colon Cancer

Dietary Folate, Alcohol, and B Vitamins in realation to hypermethylation in colon cancer [15:28m]:

Using gene signatures to predict response to infliximab.

8 Jan, 10 | by BMJ Group

In this fourth podcast Professor Laurence Egan (National University of Ireland, Galway and an associate editor of Gut) talks to Professor Paul Rutgeerts (Katholieke Universiteit Leuven, Belgium) about his latest paper on mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis.

See also:
Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis

Using gene signatures to predict response to infliximab. [15:34m]:

Cardiac output and hepatorenal syndrome

19 Nov, 09 | by BMJ Group

In this third podcast Professor Alexander Gerbes (Klinikum of the University of Munich, Germany, and an associate editor of Gut) talks to Dr Søren Møller (Hvidovre Hospital, Denmark) about his latest paper on cardiac output and hepatorenal syndrome.

See also:
Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites.

Cardiac output and hepatorenal syndrome [8:56m]:

Infliximab and Ulcerative Colitis

30 Oct, 09 | by BMJ Group

In this second podcast Professor Laurence Egan (National University of Ireland, Galway and an associate editor of Gut) talks to Dr Gordon Greenberg (Mount Sinai Hospital, Toronto) about his latest paper on infliximab and ulcerative colitis.

See also:

Trough Serum Infliximab: A Predictive Factor Of Clinical Outcome For Infliximab Therapy In Acute Ulcerative Colitis.

Infliximab and Ulcerative Colitis [14:46m]:

PPI and Barrett’s mucosa

9 Sep, 09 | by BMJ Group

Welcome to the first Gut podcast.

Each month we aim to bring you interviews with some of our researchers, giving you an insight into some of the stories behind the publication. In this first podcast Professor Ernst Kuipers (Erasmus Medical School, Rotterdam and an associate editor on Gut) talks to Professor Janusz Jankowski (Queen Mary University, London) about his latest paper on proton pump inhibitors and their effect on Barrett’s oesophagus.

See also;

Long term proton pump induced hypergastrinaemia does induce lineage-specific restitution but not clonal expansion in benign Barrett’s Esophagus in vivo

PPI and Barrats mucosa:

Latest from Gut

Latest from Gut